U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06824792) titled 'Optimal Standard Treatment Selection for Solid Tumor Patients by Biologically-informed Multi-agent System' on Feb. 07.
Brief Summary: This study is an exploratory cohort study conducted under real-world conditions, aiming to evaluate the feasibility of an artificial intelligence (AI)-guided standard treatment selection model for advanced solid tumors, as well as its superiority compared to clinician-selected treatment plans. A multi-agent system based on multimodal AI models will rank the priority of standard treatment options based on the personalized information of the patients, including including demographics, clinical informati...